Asset Acquisition - Additional Information (Detail) - USD ($) $ in Millions					1 Months Ended		3 Months Ended		12 Months Ended
	Sep. 11, 2023	Jun. 14, 2022	Jun. 08, 2022	Dec. 15, 2020	Jan. 31, 2023	Jul. 31, 2022	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2020	Sep. 30, 2023	Jul. 25, 2023	Jan. 10, 2023	Jul. 28, 2022	Jul. 25, 2022	May 31, 2022
Third Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable				$ 20.0
Achieved milestone percentage				10.00%
Contingent consideration				$ 0.1
Langer [Member] | Initial Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable by shares											$ 2.8
Stock issued during the period for milestone payments shares	249,992
Langer [Member] | Second Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable															$ 9.4
Contingent consideration payable by shares						$ 5.0
Contingent consideration payable by cash													$ 2.2	$ 2.2
Stock issued during the period for milestone payments shares			212,203
Stock issued during the period for milestone payments value			$ 5.0
Payment for contingent consideration liability					$ 2.2	2.2
Myst Holders [Member] | Initial Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable	$ 3.0
Myst Holders [Member] | Second Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable															10.0	$ 10.0
Contingent consideration payable by shares																5.0
Contingent consideration payable by cash																$ 5.0
Payment for contingent consideration liability						2.8
Remaining Myst Holders [Member] | Initial Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable by cash											$ 0.2
Remaining Myst Holders [Member] | Second Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable by cash															$ 0.6
Payment for contingent consideration liability						$ 0.6
Myst Merger Agreement [Member]
Asset Acquisition [Line Items]
Payments to acquire productive assets		$ 1.0		9.0
Research and development asset acquired other than through business combination, write-off										$ 19.4
Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff, Statement of Income or Comprehensive Income [Extensible Enumeration]										Nonoperating Income (Expense)
Asset acquisition contingent consideration arrangements change in amount of contingent consideration, liability							$ 0.0	$ 0.0
Myst Merger Agreement [Member] | Initial Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration, liability												$ 3.0
Myst Merger Agreement [Member] | Second Milestone Payment [Member]
Asset Acquisition [Line Items]
Contingent consideration payable				$ 10.0
Myst Merger Agreement [Member] | Langer [Member]
Asset Acquisition [Line Items]
Asset acquisition, consideration transferred, equity interest issued and issuable shares		725,920
Asset acquisition consideration transferred equity interest issued shares		362,960
Asset acquisition consideration transferred equity interest issuable shares		362,960
Myst Merger Agreement [Member] | Langer [Member] | Restricted Stock [Member]
Asset Acquisition [Line Items]
Percentage of vesting of award under share-based payment arrangement		25.00%
Number of equity-based payment instruments vested during the period									362,960